These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18289006)

  • 21. Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines.
    Li Q; Guo Z
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29966261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers.
    Zhou Z; Mondal M; Liao G; Guo Z
    Org Biomol Chem; 2014 May; 12(20):3238-45. PubMed ID: 24728423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships.
    Zaman M; Toth I
    Front Immunol; 2013 Oct; 4():318. PubMed ID: 24130558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines.
    Moyle PM; Dai W; Zhang Y; Batzloff MR; Good MF; Toth I
    Bioconjug Chem; 2014 May; 25(5):965-78. PubMed ID: 24712905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic vaccines: the role of adjuvants in immune targeting.
    Jiang ZH; Koganty RR
    Curr Med Chem; 2003 Aug; 10(15):1423-39. PubMed ID: 12871139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic lipopeptides as novel adjuvants.
    Bessler WG; Jung G
    Res Immunol; 1992 Jun; 143(5):548-53; discussion 579-80. PubMed ID: 1439136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic bacterial lipopeptide analogs: structural requirements for adjuvanticity.
    Ghielmetti M; Reschner A; Zwicker M; Padovan E
    Immunobiology; 2005; 210(2-4):211-5. PubMed ID: 16164028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, Characterization and Immunological Evaluation of Self-Adjuvanting Group A Streptococcal Vaccine Candidates Bearing Various Lipidic Adjuvanting Moieties.
    Fagan V; Hussein WM; Su M; Giddam AK; Batzloff MR; Good MF; Toth I; Simerska P
    Chembiochem; 2017 Mar; 18(6):545-553. PubMed ID: 28075053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccine.
    Xu Z; Rivera-Hernandez T; Chatterjee O; Walker MJ; Moyle PM
    J Control Release; 2020 Jan; 317():96-108. PubMed ID: 31758971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups.
    Chua BY; Zeng W; Lau YF; Jackson DC
    Vaccine; 2007 Jan; 25(1):92-101. PubMed ID: 17055123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.
    Vernacchio L; Bernstein H; Pelton S; Allen C; MacDonald K; Dunn J; Duncan DD; Tsao G; LaPosta V; Eldridge J; Laussucq S; Ambrosino DM; Molrine DC
    Vaccine; 2002 Nov; 20(31-32):3658-67. PubMed ID: 12399193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of a Self-Adjuvanting MUC1 Vaccine via Diselenide-Selenoester Ligation-Deselenization.
    McDonald DM; Hanna CC; Ashhurst AS; Corcilius L; Byrne SN; Payne RJ
    ACS Chem Biol; 2018 Dec; 13(12):3279-3285. PubMed ID: 30359529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T lymphocyte response induced by an improved synthetic lipopeptide vaccine against cervical cancer.
    Xu DH; Zhou CH; Xia YP; Qiu ZY; Wu YZ; Jia ZC; Zhou W
    Acta Pharmacol Sin; 2007 May; 28(5):695-702. PubMed ID: 17439726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
    PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization.
    Bessler WG; Baier W; vd Esche U; Hoffmann P; Heinevetter L; Wiesmüller KH; Jung G
    Behring Inst Mitt; 1997 Feb; (98):390-9. PubMed ID: 9382763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship of lipid, cyclic peptide and antigen rearrangement of physically mixed vaccines.
    Huang W; Madge HYR; Zhang J; Gilmartin L; Hussein WM; Khalil ZG; Koirala P; Capon RJ; Toth I; Stephenson RJ
    Int J Pharm; 2022 Apr; 617():121614. PubMed ID: 35245637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in self-adjuvanting glycoconjugate vaccines.
    Manabe Y; Chang TC; Fukase K
    Drug Discov Today Technol; 2020 Dec; 37():61-71. PubMed ID: 34895656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long Peptides.
    Reintjens NRM; Tondini E; de Jong AR; Meeuwenoord NJ; Chiodo F; Peterse E; Overkleeft HS; Filippov DV; van der Marel GA; Ossendorp F; Codée JDC
    J Med Chem; 2020 Oct; 63(20):11691-11706. PubMed ID: 32960056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.
    Cluff CW
    Adv Exp Med Biol; 2010; 667():111-23. PubMed ID: 20665204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.